Dr. Kamran Sherwani, M.D.
What this data tells you about Dr. Sherwani
Dr. Kamran Sherwani is a cardiovascular disease in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Sherwani performed 7,622 Medicare services across 4,473 unique beneficiaries.
Between the years covered by Open Payments, Dr. Sherwani received a total of $3,563 from 34 pharmaceutical and/or device companies across 158 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sherwani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Regadenoson injection (Lexiscan) for heart stress test | 1,384 | $43 | $200 |
| Electrocardiogram (EKG), 12-lead | 917 | $11 | $80 |
| Office visit, established patient (30-39 min) | 769 | $90 | $145 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 638 | $29 | $150 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 635 | $21 | $140 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 357 | $57 | $350 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 348 | $636 | $826 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 344 | $1,959 | $4,200 |
| Hospital follow-up visit, moderate complexity | 341 | $65 | $375 |
| Echocardiogram, transthoracic | 335 | $149 | $1,005 |
| Office visit, established patient (20-29 min) | 284 | $67 | $115 |
| Prothrombin time test (blood clotting) | 259 | $4 | $15 |
| Remote pacemaker monitoring, 90 days | 147 | $23 | $125 |
| Remote pacemaker/defibrillator monitoring, 90 days | 147 | $17 | $125 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 115 | $15 | $81 |
| Ultrasound of both sides of head and neck blood flow | 100 | $145 | $390 |
| Initial hospital admission, moderate complexity | 69 | $106 | $190 |
| New patient office visit (45-59 min) | 53 | $124 | $300 |
| Programming of dual lead pacemaker system | 49 | $56 | $250 |
| Insertion of heart rhythm monitor under skin | 46 | $3,580 | $9,000 |
| Hospital follow-up visit, high complexity | 42 | $98 | $425 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 41 | $148 | $450 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 34 | $139 | $400 |
| Ultrasound of leg arteries or artery grafts | 28 | $186 | $692 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $10 | $80 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 20 | $41 | $175 |
| EKG interpretation and report | 19 | $7 | $40 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $87 | $375 |
| Ultrasound of heart blood flow, valves and chambers | 17 | $14 | $110 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $2 | $55 |
| Cardiac catheterization | 13 | $240 | $3,856 |
| Emergency department visit, moderate complexity | 11 | $100 | $180 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Sherwani is a cardiac & remote specialist, with above-average Medicare volume (top 7% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Sherwani experienced with regadenoson injection (lexiscan) for heart stress test?
Does Dr. Sherwani receive payments from pharmaceutical companies?
How do Dr. Sherwani's costs compare to other cardiovascular diseases in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology